Skip to main content
Log in

Naloxone in tardive dyskinesia

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Blum I, Elizur A, Segal A, Ochshorn M, Simantov R (1983) Effect of naloxone on the neuropsychiatric symptoms of a woman with partial adrenal 21-hydroxylase deficiency. Am J Psychiatry 140:1058–1060

    Google Scholar 

  • Blum I, Munitz H, Shalev A, Roberts E (1984) Naloxone may be beneficial in the treatment of tardive dyskinesia. Clin Neuropharmacol 7:265–267

    Google Scholar 

  • Sandyk R, Snider SR (1985) Naloxone and tardive dyskinesia. Biol Psychiatr 20:1335–1336

    Google Scholar 

  • Sandyk R, Snider SR (1986) Naloxone treatment of l-dopa induced dyskinesias in Parkinson's disease Am J Psychiatry 143:118

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by a grant from Dupont Pharamceuticals (Taro Israel)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blum, I., Nisipeanu, P.F. & Roberts, E. Naloxone in tardive dyskinesia. Psychopharmacology 93, 538 (1987). https://doi.org/10.1007/BF00207250

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00207250

Keywords

Navigation